Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSX: $APH.TO,
TSX: $HEXO.TO, CSE: $MMEN.C, CSE:
$MYM.C, TSXV: $VIS.V
The United
States’ legal cannabis market is projected to reach $11 billion in consumer
spending in 2018 and more than $23 billion by 2022- Arcview Market Research
Pt. Roberts, WA; Delta, BC –June 28, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at http://www.investorideas.com/news/2018/cannabis/06284Potcasts-TSX-APH-HEXO-VIS-CSE-MMEN-MYM.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today’s podcast features
news announcements from MedMen
Enterprises Inc. trading on the CSE as MMEN and OTCQB as MMNFF, Aphria Inc. trading on the TSX as APH and the
OTCQB as APHQF, MYM Nutraceuticals Inc. trading on the CSE as MYM and
the OTC as MYMMF, Visionstate™ Corp. trading on the TSX-Venture as VIS and The Hydropothecary Corporation
trading on the TSX as HEXO.
The United States’
legal cannabis market is projected to reach $11 billion in consumer spending in
2018 and more than $23 billion by 2022, according to the “The State of Legal Marijuana Markets, Sixth
Edition” (SOLMM6) released today by Arcview Market Research in
partnership with BDS Analytics. This growth has the potential to
generate more than 467,000 full-time equivalent jobs in 2022.
According to
SOLMM6, despite federal prohibition the U.S. legal cannabis industry
experienced 31% growth in 2017 to reach $8.5 billion. Arcview forecasts that
the continuing state-by-state roll-out of medical-use programs and then
adult-use legalization, will bring nationwide spending in the U.S. to $23.4
billion in 2022, growing at a 22% compound annual growth rate over that five-year
forecast period.
The Strengthening the Tenth Amendment Through
Entrusting States (STATES) Act, introduced by a bipartisan group of
Congressional sponsors June 7 and endorsed by President Trump June 8, would
legalize that economic activity for the first time at the federal level.
“The end
of marijuana prohibition is in sight and what that means for this market
cannot be overstated,” said Troy Dayton, CEO of the Arcview Group. “There are
billions of dollars in institutional capital chomping at the bit to take
advantage of this shift, but so far haven't found a major way in. This leaves a
limited window for businesses to get a foothold and build value for liquidity
events that might come sooner than any of us thought possible just a few months
ago."
“Uruguay and
Canada are leading the way on adult-use legalization, and Germany broke
barriers in 2017 on medical-use availability. This means worldwide spending on
legal cannabis should hit $32 billion by 2022,” said Tom Adams, Editor-in-Chief
at Arcview Market Research and Managing Director of BDS Analytics’ Industry
Intelligence Division.
MedMen
Enterprises Inc. announced the forthcoming opening of its marquee location in
the heart of Downtown Las Vegas.
Today,
MedMen is scheduled to assume ownership and licensed operation of the New
Amsterdam dispensary located at 823 3rd Street. The store will be
remodeled and rebranded with MedMen’s signature design. A grand reopening is
planned for mid-July.
Nevada is
one of the fastest growing state-sanctioned marijuana markets in the country.
According to the Nevada Department of Taxation, cannabis accounted for about
$386 million of the total statewide taxable sales for the period of July 2017
through March 2018, about 19.3 percent of the state’s growth in taxable sales
compared to the same period last year.
Aphria Inc. announced
that it has closed its short form prospectus offering, on a bought deal basis,
including the exercise in full of the underwriters' over-allotment option. A
total of 21,835,510 common shares of the Company were sold at a price of
$11.85 per Share, for aggregate gross proceeds of $258,750,794. The
Offering was underwritten by a syndicate of underwriters led by Clarus
Securities Inc. and included Canaccord Genuity Corp., Cormark Securities Inc.,
Haywood Securities Inc. and INFOR Financial Inc.
The net
proceeds of the Offering are expected to be used to finance the Company's
recently announced state-of-the-art Extraction Centre of Excellence, its
capacity increase at Aphria Diamond, as well as the construction of additional
cannabis production facilities globally in both foreign and Canadian
jurisdictions where cannabis is legally permitted and the evaluation of
strategic acquisitions and investments and other industry related transactions.
MYM Nutraceuticals
Inc. and Sherbrooke College announced the signing of a partnership agreement to
develop a training program for MYM's employees assigned to the production of
cannabis. The educational curriculum will be expanded and offered as a diploma
(AEC) program as part of the Sherbrooke College (CEGEP) course offerings.
Under the
terms of this agreement, MYM retains the services of the Sherbrooke College
(CEGEP) Continuing Education Center to develop and deliver tailor-made training
and learning programs leading to a diploma (AEC) in the fields of production,
agricultural management and associated laboratory techniques specific to the
production of cannabis. The agreement is valid for a five-year period,
beginning July 1, 2018. Upon construction of the Company's production facility
in Weedon, Québec being completed, the Company anticipates using such facility
to provide certain physical and technical resources to the Continuing Education
Center.
Visionstate™
Corp. announced that it has made a strategic investment in Alberta-based
Freedom Cannabis Incin a round of seed funding. The investment into Freedom
Cannabis was made on the basis of synergies that exist between the businesses
with respect to potential sensor development for monitoring production processes
and opportunities to leverage solar powered backyard greenhouses for the home
growing market through Visionstate’s investment in Exceed Solar Inc.
The Cannabis
Act was recently passed in the Canadian Senate, with production and use
expected to become legal on October 17th 2018. “As the cannabis
industry emerges in Canada, we see tremendous opportunity in partnering with
Freedom Cannabis,” says Visionstate Corp. CEO John Putters, “particularly for
integrating our IoT connected sensors and solar applications into the
production process.”
Visionstate
Inc., a wholly owned subsidiary of Visionstate Corp., is an Internet of Things
(IoT) company that specializes in data collection and analytics through sensor
data. The Company’s core product, WANDA™, is an IoT touch-screen solution that
collects information on cleaning activities, monitors supply inventories,
collects foot-traffic data using people sensors and provides detailed
analytics, with a reporting dashboard that enables data-driven operational
decisions.
“The
cannabis industry offers huge potential for sensor applications, particularly
in monitoring and quality control,” Putters explains. “Our relationship with
Freedom Cannabis provides the opportunity to enter this potentially lucrative
market.”
The Hydropothecary
Corporation reported its financial results for the three and nine months ended
April 30, 2018, the third quarter of the 2018 fiscal year. The management
discussion and analysis for the period and the accompanying financial
statements and notes are available under the Company's profile on SEDAR
at www.sedar.com and
on its website at www.HEXO.com.
All amounts are expressed in Canadian dollars.
The
highlights include:
·
Revenue per
gram increased to $9.24 per gram equivalent from $8.99 in the prior quarter,
and $8.62 in the third quarter of fiscal 2017.
·
Weighted
average cash cost of dried inventory sold per gram of $0.88 has decreased 57%
year-over-year compared to the third quarter of fiscal 2017.
·
Revenue
increased 5% to $1,240,172 and the volume of medical cannabis sold increased 2%
to 134,253 gram equivalents from the second quarter of fiscal 2018.
·
Finalization
of the commercial supplier agreement with Société québécoise du cannabis (SQDC)
to supply approximately 200,000 kg of cannabis over a five-year term.
·
20,000 kg of
cannabis to be supplied to the SQDC in year one of the supplier agreement post
legalization.
·
Cash and
short-term investments of $248.9 million as at April 30, 2018, debt-free
balance sheet.
·
Launch of
the new recreational adult-use cannabis brand HEXO.
·
First plants
planted in newly licensed zones of the new 250,000 sq. ft facility.
·
Graduated to
the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSXV) with the
common shares now trading under the symbol HEXO.
·
Announcement
of intention to change the Company name to HEXO Corp. from the Hydropothecary
Corporation.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
